Lotte Biologics Co. has secured a contract manufacturing deal with Rakuten Medical Inc. for a head and neck cancer drug, aiming to expand its global CMO presence and build a supply chain from clinical trials to commercialization.
#YonhapInfomax #LotteBiologics #RakutenMedical #ContractManufacturing #HeadAndNeckCancer #SyracuseBioCampus #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=99683
Lotte Biologics Secures Contract Manufacturing Deal for Head and Neck Cancer Drug—Aims to Sustain Order Momentum

Lotte Biologics Co. has secured a contract manufacturing deal with Rakuten Medical Inc. for a head and neck cancer drug, aiming to expand its global CMO presence and build a supply chain from clinical trials to commercialization.

Yonhap Infomax
Lotte Biologics has signed a contract manufacturing agreement with OTTIMO Pharma to produce antibody drug substances at its Syracuse Bio Campus, strengthening its global CDMO presence.
#YonhapInfomax #LotteBiologics #OTTIMOPharma #AntibodyDrug #CDMO #SyracuseBioCampus #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=68343
Lotte Biologics Signs Antibody Drug Manufacturing Agreement with OTTIMO Pharma

Lotte Biologics has signed a contract manufacturing agreement with OTTIMO Pharma to produce antibody drug substances at its Syracuse Bio Campus, strengthening its global CDMO presence.

Yonhap Infomax
Lotte Biologics secures first ADC production contract, signaling full operation of its New York facility and expansion into global ADC CDMO market
#YonhapInfomax #LotteBiologics #ADCProduction #CDMOServices #BiotechContract #SyracuseBioCampus #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=60084
Lotte Biologics Secures First ADC Clinical Candidate Production Contract

Lotte Biologics secures first ADC production contract, signaling full operation of its New York facility and expansion into global ADC CDMO market

Yonhap Infomax